Rut and Klaus Bahlsen Foundation supports the establishment with two million euros

Topics include the award of a young colleague from the Max Eder Young Investigator Program of the German Cancer Aid, the MHH membership in the European reference network GENTURIS and the first success story of the HANSE lung check study at the MHH.

Dr. Thomas Wirth, Senior Physician at the Clinical Department of Gastroenterology, Hepatology and Endocrinology at the MHH

"No symptoms were recognizable to me"

24-year-old Laura Hinze receives a grant worth almost three quarters of a million euros from German Cancer Aid

Topics include the establishment of the Centres for Personalized Medicine (ZPM) at the Göttingen and Hanover sites, the exchange between the cross-site working groups in the CCC-N and the first scientific retreat "Translational Research". In addition, a new series of events entitled "Oncological Care Reality Lower Saxony" will be launched for physicians, documentalists and medical professionals.

German Research Foundation funds MHH Clinical Department of Nuclear Medicine with around 900,000 euros for the expansion of molecular imaging

"On the images from the new CT, for example, the fine lines of lung tumors are much easier to see. This allows us to provide surgeons and oncologists with more precise information about the spread of the tumor," explains Professor Wacker.

International team takes important step towards a better understanding of the manifestations of hereditary disease

20,000 women from the Hanover region to take part in study to improve prevention

MHH research team finds biomarker for treatment success in donor lymphocyte infusion

Topics covered in this issue include the OnkoRiskNET project, a cooperation network for the close-to-home care of patients and families with a genetic tumor risk, the MyPal pediatric oncology app, the VITU video conferencing system for virtual tumor boards and the SICKO training concept for safety in pediatric oncology.

Nationwide study with 50 years of data determines cancer risk of those affected

During Breast Cancer Awareness Month in October, the focus worldwide is on prevention, early detection and research into breast cancer in order to raise awareness of the disease. The CCC Hannover supports the month of action and provides information, including a video on the topic of breast cancer prevention. Further information can be found on the topic page.

More awareness of head and neck tumors: improving the chances of a cure through education and early detection. The CCC Hannover is involved with the Head and Neck Tumor Center.

The focus is on vaccinations for children that reduce the risk of certain cancers in adulthood. The CCC Hannover is taking part in the campaign week. Further information on the topic page.

HPV as a risk factor, how I can protect myself and why prevention is important. With Dr. Matthias Jentschke, Senior Physician at the Clinical Department of Gynaecology and Obstetrics at the MHH.

These are our topics: Tasks and goals of the Lower Saxony Unified Biobank (LSUB), Prof. Dr. Hans Christiansen of the MHH is a new member of the board of the Lower Saxony Cancer Society, the Franziskus Hospital Bielefeld and the Oncology Association of Northern Hesse introduce themselves, a review of the CCC-N's participation in the DKH's cycling campaign and upcoming events.

Topics include current study results on breast cancer risk genes, the Hanse Prevention Program for former and active smokers, the study "Loving parenting - despite cancer" as well as psycho-oncological group therapy for young adults with cancer, the CCC's participation in the DKH cycling campaign and events in 2021.

The Comprehensive Cancer Center Lower Saxony is participating in the German Cancer Aid's cycling campaign from June 25 to July 4, 2021

Study results of the Breast Cancer Association Consortium (BCAC) with participation of the MHH show disease-specific potential of further gene mutations in breast cancer

Prof. Dr. Hans Christiansen of the Comprehensive Cancer Center of the MHH elected to the board of the Lower Saxony Cancer Society

MHH involved in HANSE prevention program for former and active smokers

Online event of the Comprehensive Cancer Center Hannover of the MHH for patients, relatives and interested parties on June 28 from 5 p.m. to 8 p.m.

Research team investigates the role of connective tissue cells in the tumor environment

An interview with the two medical directors of the Molecular Tumor Board on the goals and possibilities of the MTB, the presentation of the Cancer Center Braunschweig (CCB) and the Cancer Center Klinikum Region Hannover (KRH), the smoking cessation programs at the UMG and MHH as well as upcoming events at the CCC-N.

Smoking contributes significantly to the development of various cancers, cardiovascular diseases and lung diseases. Quitting smoking can reduce the risk of these diseases. Smoke-free programs offer support here. Read more about the smoke-free program at the MHH and "Smoking as the most important risk factor for lung cancer" here.

What tests are there? How do they work? What are the advantages and disadvantages of the tests? An interview with Dr. Inga Peters from the Clinical Department of Urology and Urological Oncology. Listen now on YouTube.

Prof. Dr. P. Christian Kratz, Director of the Clinical Department of Pediatric Hematology and Oncology at MHH, will give the "Frederick P. Li Lecture" for cancer research at the Dana-Farber Cancer Institute, Harvard Medical School, on May 20. The title of the lecture is "Cancer Predisposition Syndromes - Moving from Syndrome to Spectrum".

Bärbel Dütemeyer from the Verein für krebskranke Kinder Hannover explains how our children's cancer units are supported.

The award of the MHH and UMG as an Oncology Center of Excellence and further articles on the topic of research and treatment of cancer at the CCC Hannover (Claudia von Schilling Center) of the MHH.

What is the most important risk factor for skin cancer? How can the A-B-C-D-E rule help me? In a short video, Prof. Dr. Alexander Kapp, Director of the Clinical Department of Dermatology, Allergology and Allergy at the MHH, explains skin cancer prevention and what changes you can look out for yourself.

More important than ever? How can psycho-oncology help at this time? What services are currently available? We answer these and other questions in the second episode of our podcast with Prof. Zimmermann, Professor of Psychosomatics and Psychotherapy. Listen now on YouTube.

MHH research team investigates molecular biomarkers for individualized tumor therapy

Wanted at the earliest possible date! Application deadline: 30.04.2021. Click here for the job advertisement...

A conversation with Prof. Dr. Christine Falk, Head of the Institute of Transplantation Immunology at the MHH on the subject of corona vaccination for cancer. Listen now on YouTube.

The BRCA network is receiving an increasing number of concerned inquiries about this issue. The BRCA Network is therefore providing further information, including a statement on coronavirus vaccinations for familial cancers.

Topics in this issue include the cooperation between the Clinical Department of Neurosurgery at MHH and the Clinical Department of Neurology at Henriettenstift DIAKOVERE, a study on a home-based training and care program (CRBP-TS) for cancer patients and the certification of our lung cancer center by the DKG.

An interview with Prof. Dr. Hans Heinrich Wedemeyer, Director of the Clinical Department of Gastroenterology, Hepatology and Endocrinology at the MHH on myths, fears and concerns about colorectal cancer and colorectal cancer screening on the occasion of Colorectal Cancer Awareness Month in March.

Successful teamwork: MHH haematologists carried out a total of 96 blood stem cell transfusions in 2020 - despite coronavirus conditions.

New technology-based approach to therapy provision: Institute of Sports Medicine at the MHH is investigating online-supported training for cancer patients in a collaborative project.

MHH project aims to expand genetic counseling and diagnostics nationwide - innovation fund supports OnkoRisk NET with 2.5 million euros

The Hannover Medical School's online event reached more than 300 professionals - throughout Lower Saxony and beyond.

MHH and Göttingen conclude a CCC-N contract with the AOK Lower Saxony

In this issue, you can read all about the German Cancer Aid's award as an Oncology Center of Excellence and about the future goals and plans of the CCC Lower Saxony...

CCC Hannover study gives hope: interim results for the first wave show no slump.

Breast cancer screening - how can I take precautions and what symptoms should I be aware of? Skin cancer screening - what changes should I look out for? You can find the explanatory videos in our media library!

The Comprehensive Cancer Center Niedersachsen (CCC-N) is funded by German Cancer Aid as an Oncological Center of Excellence. This decision was announced by German Cancer Aid (DKH) on February 3, 2021.

The aim of World Cancer Day is to raise public awareness of the prevention, research and treatment of cancer. This year, we would like to remind people of ways in which they can reduce their risk of developing cancer.

MHH research team uses telomerase for oxygen detoxification in heart muscle cells.

As one of the largest oncological nursing training courses in northern Germany, the MHH's Oncological Nursing Day will take place as an online event on February 6, 2021 under the motto "For each other - With each other - From each other". Click here for the program.